Blueweave
Global Respiratory Care Devices Market Bwc19312

Global Respiratory Care Devices Market Bwc19312

SPECIAL OFFER : 25% Super Discount For All !

Global Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, Pap Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), End User (Hospital, Home Care), Indication (COPD, Asthma, And Chronic Infectious Diseases), By Region (North America, Europe, Asia Pacific, Middle East & Africa and Latin America); Trend Analysis, Competitive Market Share & Forecast, 2015-2025

  • Published Date: October 2019
  • Report ID: BWC19312
  • Available Format: PDF
  • Page: 125

1.    Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary & Secondary Sources

2.2. Quantitative Research

2.2.1.   Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents, By Industry Participants

2.5. Market Size Estimation

2.6. Assumption for the Study

2.7. Market Breakdown & Data Triangulation

3.    Executive Summary

4.    Global Respiratory Care Devices Market - Industry Insights

4.1. Value Chain Analysis

4.2. DROC Analysis

4.2.1.   Growth Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.2.4.   Challenges

4.3. Technological Landscape

4.4. Regulatory Framework

4.5. Company Market Share Analysis,2018

4.6. Porter’s Five Forces Analysis

4.7. Pest Analysis

4.8. Strategic Outlook

5.    Global Respiratory Care Devices Market Overview

5.1. Market Size & Forecast

5.1.1.   By Value (USD Million)

5.2. Market Share & Forecast, 2015 – 2025

5.2.1.   By Product

5.2.1.1.       Therapeutic Devices

5.2.1.1.1.           PAP Devices

5.2.1.1.1.1.              Continuous Positive Airway Pressure (CPAP) Devices

5.2.1.1.1.2.              Automatic PAP (APAP) Device

5.2.1.1.1.3.              Bi-Level PAP (BPAP) Devices

5.2.1.1.2.           Ventilators

5.2.1.1.2.1.              ICU Ventilators (High-end, Mid-end and Basic)

5.2.1.1.2.2.              Portable/Transportable Ventilators

5.2.1.1.3.           Nebulizers

5.2.1.1.4.           Humidifiers

5.2.1.1.4.1.              Heated Humidifiers

5.2.1.1.4.2.              Passover Humidifiers

5.2.1.1.5.           Oxygen Concentrators

5.2.1.1.5.1.              Fixed Oxygen Concentrators

5.2.1.1.5.2.              Portable Oxygen Concentrators

5.2.1.1.6.           Inhalers

5.2.1.1.6.1.              Metered Dose Inhalers (MDIs)

5.2.1.1.6.2.              Dry Powder Inhalers (DPIs)

5.2.1.1.7.           Reusable Resuscitators

5.2.1.1.7.1.              Adult Resuscitators

5.2.1.1.7.2.              Infant/Neonatal Resuscitators

5.2.1.1.8.           Nitric Oxide Delivery Units

5.2.1.1.9.           Oxygen Hoods

5.2.1.2.       Monitoring Devices

5.2.1.2.1.           Pulse Oximeters

5.2.1.2.1.1.              Pulse oximeter sensors

5.2.1.2.1.2.              Pulse Oximeter equipment

5.2.1.2.2.           Capnographs

5.2.1.2.3.           Gas Analyzers

5.2.1.3.       Diagnostic Devices

5.2.1.3.1.           Spirometers

5.2.1.3.2.           Polysomnography Devices

5.2.1.3.3.           Peak Flow Meters

5.2.1.3.4.           Other Diagnostic Devices

5.2.1.4.       Consumables and Accessories

5.2.1.4.1.           Masks

5.2.1.4.1.1.              Reusable Masks (nasal, Full-Face, Nasal Pillow, Oral Mask)

5.2.1.4.1.2.              Disposable Mask

5.2.1.4.2.           Disposable Resuscitators

5.2.1.4.3.           Breathing Circuits

5.2.1.4.4.           Tracheostomy Tubes

5.2.1.4.5.           Nasal Cannulas

5.2.2.   By Indication

5.2.2.1.       Chronic Obstructive Pulmonary Disease (COPD)

5.2.2.2.       Asthma

5.2.2.3.       Sleep Apnea

5.2.2.4.       Infectious Disease

5.2.2.5.       Others (lung cancer, tuberculosis, and idiopathic pulmonary fibrosis etc.)

5.2.3.   By End User

5.2.3.1.       Home Care Setting

5.2.3.2.       Hospitals & Clinics

5.2.3.3.       Ambulatory Care Center

5.2.4.   By Region

5.2.4.1.       North America

5.2.4.2.       Europe

5.2.4.3.       Asia-Pacific

5.2.4.4.       Latin America

5.2.4.5.       Middle East and Africa

6.    North America Respiratory Care Devices Market

6.1. Market Estimates & Forecast, 2015 - 2025

6.1.1.   By Product

6.1.2.   By Indication

6.1.3.   By End User

6.1.4.   By Country

6.1.4.1.       US

6.1.4.2.       Canada

7.    Europe Respiratory Care Devices Market

7.1. Market Estimates & Forecast, 2015 - 2025

7.1.1.   By Product

7.1.2.   By Indication

7.1.3.   By End User

7.1.4.   By Country

7.1.4.1.       UK

7.1.4.2.       Germany

7.1.4.3.       France

7.1.4.4.       Russia

7.1.4.5.       Spain

8.    Asia-Pacific Respiratory Care Devices Market

8.1. Market Estimates & Forecast, 2015 - 2025

8.1.1.   By Product

8.1.2.   By Indication

8.1.3.   By End User

8.1.4.   By Country

8.1.4.1.       China

8.1.4.2.       India

8.1.4.3.       Japan

8.1.4.4.       South Korea

9.    Latin America Respiratory Care Devices Market

9.1. Market Estimates & Forecast, 2015 - 2025

9.1.1.   By Product

9.1.2.   By Indication

9.1.3.   By End User

9.1.4.   By Country

9.1.4.1.       Brazil

9.1.4.2.       Mexico

10. Middle East & Africa Respiratory Care Devices Market

10.1.             Market Estimates & Forecast, 2015 - 2025

10.1.1. By Product

10.1.2. By Indication

10.1.3. By End User

10.1.4. By Country

10.1.4.1.    Saudi Arabia

10.1.4.2.    UAE

10.1.4.3.    South Africa

11. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

11.1.             Philips Healthcare

11.2.             Resmed, Inc.

11.3.             Medtronic PLC

11.4.             Masimo Corporation

11.5.             Fisher and Paykel Healthcare Co., Ltd.

11.6.             Getinge AB

11.7.             Air Liquide

11.8.             Drägerwerk AG & Co. KGaA

11.9.             Hamilton Medical AG

11.10.          Invacare Corporation

11.11.          Other Prominent Player

12. Strategic Recommendation

*Financial Details Not Be Captured in Case of Unlisted Companies

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable.